Last Updated : December 2, 2022
The class of sodium-glucose cotransporter 2 (SGLT2) inhibitors is an integral part of the management of type 2 diabetes. This review will assess the evidence regarding the clinical effectiveness and harms of SGLT2 inhibitors compared to other glucose lowering drugs in adults with type 2 diabetes. The focus of the report will be on summarizing and appraising recent (from 2020 to present) systematic reviews with meta-analyses.
Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and expected completion dates may change. Find out more about Projects in Progress.
The “Projects in Progress” page on the CADTH website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. View our current Projects in Progress.